Treatment of Ischemic Or Dilated Cardiomyopathy

Links shared publicly online about this topic

Dilated Cardiomyopathy Symptoms

mayoclinic.com — “Dilated cardiomyopathy — Comprehensive overview covers symptoms, causes, diagnosis and treatment of this heart disorder.View full resource at mayoclinic.com

  • View Related
  • Share

Most Recently Shared on December 3, 2009 at 8:47 pm By:

Heart_Blood Heart & Blood OW OW Health

Dilated cardiomyopathy and shortness of breath: A symptom of dilated cardiomyopathy: http://bit.ly/9e3ROP

2 years ago...

Cardiology Article | Cardiomyopathy, Dilated

mdlinx.com — “Pacing treatment for dilated cardiomyopathy: optimization of resynchronization pacing in pediatricsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 12, 2010 at 12:11 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Pacing treatment for dilated cardiomyopathy: optimization of resynchronization pacing in pediatrics:... http://bit.ly/9ehnYX #cardiology

2 years ago...

Symptoms and treatment: Dilated Cardiomyopathy - by Nicole Evans M.D. - Helium

helium.com — “Dilated cardiomyopathy is enlargement of the left or right ventricle of the heart. This dilation causes a loss of cardiac contractile function whi..., Nicole Evans M.D.View full resource at helium.com

  • View Related
  • Share

Most Recently Shared on February 10, 2011 at 6:04 am By:

Dilated cardiomyopathy: Risk factors - MayoClinic.com

mayoclinic.com — “Dilated cardiomyopathy — Comprehensive overview covers symptoms, causes, diagnosis and treatment of this heart disorder.View full resource at mayoclinic.com

  • View Related
  • Share

Most Recently Shared on August 19, 2010 at 2:14 pm By:

Health_SS Susan S Health Advocate

Dilated cardiomyopathy and alcohol: Dilated cardiomyopathy risk factors: http://bit.ly/ddVcdY

2 years ago...

Aastrom Biosciences initiates treatment in Phase 2 catheter-based clinical trial for dilated cardiomyopathy

news-medical.net — “Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the first patient has been treated in the company's U.S. Phase 2 catheter-based clinical trial to treat dilated cardiomyopathy (DCM). Treatment was performed by interventional cardiologist Timothy D. Henry, M.D., FACC, at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis, MN.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 17, 2010 at 3:13 pm By:

NewsMedical News-Medical.Net Health News

Aastrom Biosciences initiates treatment in Phase 2 catheter-based clinical trial for dilated cardiomyopathy: Aastr... http://bit.ly/9WC6dJ

2 years ago...

ICDs Need To Be Flexible And Durable Enough For Patients Living Longer

medicalnewstoday.com — “Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients witView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 5, 2011 at 10:58 am By:

Drugs_Devices Drugs and Devices OW OW Health

ICDs Need To Be Flexible And Durable Enough For Patients Living Longer: Most patients with ischemic c... http://bit.ly/gvUxM6 #MedDevice

1 year ago...

ICDs Need To Be Flexible And Durable Enough For Patients Living Longer

medicalnewstoday.com — “Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients witView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 5, 2011 at 10:06 am By:

mnt_heart MNT Heart News Health News

ICDs Need To Be Flexible And Durable Enough For Patients Living Longer http://mnt.to/3T9G #heart #heartdisease

1 year ago...

Are implantable cardioverter-defibrillators (ICDs) up to par with patients living longer?

sciencedaily.com — “Most patients with ischemic cardiomyopathy and dilated cardiomyopathy who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease can live for decades, according to new research.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on April 4, 2011 at 4:16 pm By:

sciencedaily sciencedaily Health News

Are implantable cardioverter-defibrillators (ICDs) up to par with patients living longer?: Most patients with is... http://bit.ly/gqxi9U

1 year ago...

Are ICDs up to par with patients living longer?

physorg.com — “Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease can live for decades, based on a scientific paper that will be presented at the ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on April 4, 2011 at 2:27 pm By:

Aastrom commences extension study for control patients from Phase 2 IMPACT-DCM clinical trial

news-medical.net — “Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced the initiation of an extension study for control patients from the company's ongoing open-label Phase 2 IMPACT-DCM clinical trial in patients with dilated cardiomyopathy (DCM).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 14, 2010 at 2:25 pm By:

NewsMedical News-Medical.Net Health News

Aastrom commences extension study for control patients from Phase 2 IMPACT-DCM clinical trial: Aastrom Biosciences... http://bit.ly/bS0atZ

2 years ago...

Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial : The Lancet

thelancet.com — “Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. By - Prof Roberto Bolli MD, Atul R Chugh MD, Domenico D'Amario MD, John H Lough...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on November 14, 2011 at 2:10 pm By:

TheLancet The Lancet Medical Journal

First-in-man study shows cardiac stem cells show promise for treating heart failure caused by ischaemic heart disease http://t.co/jwklyA2h

6 months ago...

Dabaghi Plans "First-in-Man" Human Cord Blood Stem Cell Treatments For Heart Failure

medicalnewstoday.com — “Dabaghi Therapeutics, Inc., a stem cell and gene therapy pioneer, announced today plans for the world's first Human Cord Blood (HCBC) stem cell treatment clinical trial via Intramyocardial deliverView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 17, 2010 at 1:38 pm By:

HeartsHealth Heart Health Health News

MedicalNewsToday: Dabaghi Plans "First-in-Man" Human Cord Blood Stem Cell Treatments For: http://bit.ly/aCzoTX Full http://bit.ly/9N2RqW

2 years ago...

The Alliance For The Advancement Of Adult Stem Cell Therapy And Research Announces Successful Treatment Of End-Stage Heart Disease With Stem Cells

medicalnewstoday.com — “Zannos grekos, md, associate clinical professor at nova southeastern university, has announced six month follow-up results for a patient treated with adult stem cells in a clinical study of idiopaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 23, 2009 at 5:14 pm By:

HeartsHealth Heart Health Health News

MedicalNewsToday: The Alliance For The Advancement Of Adult Stem Cell Therapy And: http://tinyurl.com/lzkkyz Full http://tinyurl.com/mby2sq

3 years ago...

Roberto Bolli, MD, to Discuss Cardiac Stem Cell Treatment for Heart Failure

newswise.com — “Bolli and colleagues are conducting the groundbreaking study, "Cardiac Stem Cell Infusion in Patients with Ischemic cardiOmyopathy (SCIPIO)," to perfect a technique for using a patient's own cardiac stem cells to regenerate dead heart muscle after a heart attack.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on April 10, 2011 at 2:11 am By:

Heart_Blood Heart & Blood OW OW Health

Roberto Bolli, MD, to Discuss Cardiac Stem Cell Treatment for Heart Failure: Bolli and colleagues are conducting... http://bit.ly/ef6Z3Y

1 year ago...

Roberto Bolli, MD, to Discuss Cardiac Stem Cell Treatment for Heart Failure

newswise.com — “Bolli and colleagues are conducting the groundbreaking study, "Cardiac Stem Cell Infusion in Patients with Ischemic cardiOmyopathy (SCIPIO)," to perfect a technique for using a patient's own cardiac stem cells to regenerate dead heart muscle after a heart attack.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on April 9, 2011 at 10:18 pm By:

newswise newswise Health Communicator and Health News

Roberto Bolli, MD, to Discuss Cardiac Stem Cell Treatment for Heart Failure: Bolli and colleagues are conducting... http://bit.ly/i5qGGA

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • Heart_Blood

    Heart & Blood OW

    Organizing heart and blood resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • IntegrateMD

    Nicole Evans M.D.

    I'm a resident physician with a passion for Integrative Medicine. I love sharing info on health, disease & the art of medicine.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390